Addressing Development and Use of Chemical and Biological Weapons by Russia - DFOP0017240
Request Ticket // Limit: 1 // Tickets Available: 1
Limiting Language
Applicants can submit one application in response to the NOFO. If more than one application is submitted by an organization, only the final application received, and time stamped by grants.gov will be reviewed for eligibility. Each application can include multiple projects that will be evaluated independently.
Executive Summary
The Director of National Intelligence assesses that Russian scientific institutes continue to research and develop chemical and biological weapons (CBW) capabilities, including technologies to deliver CBW agents. Russia retains an undeclared chemical weapons program and has used chemical weapons at least twice during recent years in assassination attempts with Novichok nerve agents, also known as fourth-generation agents, against Russian opposition leader Aleksey Navalny in 2020, and against U.K. citizen Sergey Skripal and his daughter Yuliya Skripal on U.K. soil in 2018. Russian forces almost certainly continue using chemicals against Ukrainian forces, with hundreds of reported attacks occurring since late 2022.
In response to this very specific national security threat, ISN/CTR will engage biological, biotechnology, chemical, and pharmaceutical (BBCP) industry on compliance and due diligence best-practices to protect manufacturing and distribution supply chains from Russian acquisition of material and equipment for CBW development. In the instances of use, ISN/CTR will train first responders to assess and secure contamination sites and collect and transport samples to maintain a proper chain of custody to a detection laboratory. ISN/CTR will also train laboratory staff in CBW detection methods to ensure beneficiaries are technically proficient to detect CBW use, as well as strengthen cybersecurity via assessments and select upgrades to protect detection processes, documentation, and reporting.